144 related articles for article (PubMed ID: 33002201)
1. Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes.
Sananmuang T; Yu E; Su J; O'Sullivan B; Rathod S; Chan B; Bartlett E; Waldron J; Ringash J; Kim J; Bratman SV; Hope A; Spreafico A; Hansen AR; de Almeida J; Goldstein DP; Witterick I; Tong L; Xu W; Huang SH
Laryngoscope; 2021 Apr; 131(4):E1162-E1171. PubMed ID: 33002201
[TBL] [Abstract][Full Text] [Related]
2. Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Billfalk-Kelly A; Yu E; Su J; O'Sullivan B; Waldron J; Ringash J; Bartlett E; Perez-Ordonez B; Weinreb I; Bayley A; Bratman SV; Cho J; Giuliani M; Hope A; Hosni A; Kim J; Hansen AR; de Almeida J; Tong L; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1017-1027. PubMed ID: 30953712
[TBL] [Abstract][Full Text] [Related]
3. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
Huang SH; O'Sullivan B; Su J; Bartlett E; Kim J; Waldron JN; Ringash J; de Almeida JR; Bratman S; Hansen A; Bayley A; Cho J; Giuliani M; Hope A; Hosni A; Spreafico A; Siu L; Chepeha D; Tong L; Xu W; Yu E
Radiother Oncol; 2020 Mar; 144():13-22. PubMed ID: 31710939
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography performance in predicting extranodal extension in HPV-positive oropharynx cancer.
Faraji F; Aygun N; Coquia SF; Gourin CG; Tan M; Rooper LM; Eisele DW; Fakhry C
Laryngoscope; 2020 Jun; 130(6):1479-1486. PubMed ID: 31411751
[TBL] [Abstract][Full Text] [Related]
6. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
7. Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.
Kwan JYY; Su J; Huang SH; Ghoraie LS; Xu W; Chan B; Yip KW; Giuliani M; Bayley A; Kim J; Hope AJ; Ringash J; Cho J; McNiven A; Hansen A; Goldstein D; de Almeida JR; Aerts HJ; Waldron JN; Haibe-Kains B; O'Sullivan B; Bratman SV; Liu FF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1107-1116. PubMed ID: 29506884
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.
Pilar A; Yu E; Su J; O'Sullivan B; Bartlett E; Waldron JN; Ringash J; Spreafico A; Hansen AR; de Almeida J; Bayley A; Bratman SV; Cho J; Giuliani M; Hope A; Hosni A; Kim J; Tong L; Xu W; Huang SH
Oral Oncol; 2021 Mar; 114():105167. PubMed ID: 33508706
[TBL] [Abstract][Full Text] [Related]
9. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
Lassen P; Huang SH; Su J; Waldron J; Andersen M; Primdahl H; Johansen J; Kristensen CA; Andersen E; Eriksen JG; Hansen CR; Alsner J; Lilja-Fisher J; Bratman SV; Ringash J; Kim J; Hope A; Spreafico A; de Almeida J; Xu W; O'Sullivan B; Overgaard J
Int J Cancer; 2022 Apr; 150(8):1329-1340. PubMed ID: 34792199
[TBL] [Abstract][Full Text] [Related]
11. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.
Huang SH; Perez-Ordonez B; Weinreb I; Hope A; Massey C; Waldron JN; Kim J; Bayley AJ; Cummings B; Cho BC; Ringash J; Dawson LA; Siu LL; Chen E; Irish J; Gullane P; Hui A; Liu FF; Shen X; Xu W; O'Sullivan B
Oral Oncol; 2013 Jan; 49(1):79-85. PubMed ID: 22917550
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers.
El Asmar M; Tsai HL; Fakhry C; Maroun CA; Mandal R; Pardoll DM; Wang H
Oral Oncol; 2019 Feb; 89():23-29. PubMed ID: 30732954
[TBL] [Abstract][Full Text] [Related]
13. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Distant Metastasis after Radical Surgery Followed by Postoperative Radiotherapy with or without Chemotherapy for Oropharyngeal Cancer.
Chung MJ; Kim YS; Kim JY; Lee YH; Jang JH; Kang JH; Yoo IR; Lee YS
Cancer Res Treat; 2016 Oct; 48(4):1167-1176. PubMed ID: 26987396
[TBL] [Abstract][Full Text] [Related]
15. Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
Wong ET; Huang SH; O'Sullivan B; Persaud V; Su J; Waldron J; Goldstein DP; de Almeida J; Ringash J; Kim J; Hope A; Bratman S; Cho J; Giuliani M; Hosni A; Spreafico A; Hansen A; Tong L; Xu W; Yu E
Radiother Oncol; 2021 Apr; 157():255-262. PubMed ID: 33600871
[TBL] [Abstract][Full Text] [Related]
16. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH; O'Sullivan B; Xu W; Zhao H; Chen DD; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BC; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1078-85. PubMed ID: 24210079
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
[TBL] [Abstract][Full Text] [Related]
18. Morphologic and topographic radiologic features of human papillomavirus-related and -unrelated oropharyngeal carcinoma.
Chan MW; Yu E; Bartlett E; O'Sullivan B; Su J; Waldron J; Ringash J; Bratman SV; Chen YA; Irish J; Kim J; Gullane P; Gilbert R; Chepeha D; Perez-Ordonez B; Weinreb I; Hansen A; Tong L; Xu W; Huang SH
Head Neck; 2017 Aug; 39(8):1524-1534. PubMed ID: 28580605
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma.
Tian S; Ferris MJ; Switchenko JM; Magliocca KR; Cassidy RJ; Jhaveri J; Aiken AH; Baugnon KL; Hudgins PA; Kendi ATK; Patel MR; Saba NF; Curran WJ; Beitler JJ
Head Neck; 2019 Sep; 41(9):3056-3063. PubMed ID: 31046181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
